Search - tctmd.com

Displaying 1 - 20 of 52

Sort: Relevancy | Date

Presentation TCT 2025

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

Presenter: Zeyad Kholeif

October 27, 2025

Presentation TCT 2025

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

Presenter: Pushan Aggarwal

October 27, 2025

Presentation NY Valves 2024

Direct Oral Anticoagulants Versus Vitamin K Antagonists After TAVR

Presenter: Agam Bansal

June 06, 2024

Presentation TCT 2023

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

Presenter: Sanjit Jolly

October 25, 2023

Presentation TVT 2023

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis

Presenter: Mustafa Suppah

June 08, 2023

Presentation TVT 2023

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

Presenter: Olayiwola Bolaji

June 08, 2023

Presentation TCT 2022

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

Presenter: Khawaja Akhtar

September 19, 2022

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

Presentation TCT 2022

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Presenter: Davide Cao

September 18, 2022

Presentation TVT 2022

Real World Outcomes of Left Atrial Appendage Occlusion compared to Novel Oral Anticoagulants - A multicenter electronic health record analysis

Presenter: Arka Chatterjee

June 10, 2022

Presentation TCT 2020

TCT 449: Direct Oral Anticoagulants vs. Warfarin Following Left Atrial Appendage Occlusion: A Study-Level Meta-Analysis

Presenter: Aravdeep Jhand

October 14, 2020

Presentation SIF 2019

Fundamentals of Pharmacology: What You Need to Know as an Interventionalist

Presenter: Sripal Bangalore

March 27, 2019

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr.

September 24, 2018

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticouagulants

Presentation ACC 2018

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Presenter: Steve Deitelzweig

March 12, 2018

Presentation TCT 2017

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Samir R. Kapadia, David J. Moliterno

November 01, 2017

Presentation TCT 2017

What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants

Presenter: Robert A. Harrington, Kurt Huber, Freek W.A. Verheugt

November 01, 2017

Presentation TCT 2017

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy

Presenter: Robert A. Harrington, Kurt Huber, Renato D. Lopes

November 01, 2017

Presentation

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

May 24, 2017

Presentation Fellows 2017

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Manish A. Parikh, David J. Cohen

April 07, 2017

Presentation

New Oral Anticoagulants: Are the Best Options

Presenter: Roberta Rossini

February 10, 2017

Advertisement

TCT 713: Outcomes of Left Atrial Appendage Occlusion vs. Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

Direct Oral Anticoagulants Versus Vitamin K Antagonists After TAVR

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Real World Outcomes of Left Atrial Appendage Occlusion compared to Novel Oral Anticoagulants - A multicenter electronic health record analysis

TCT 449: Direct Oral Anticoagulants vs. Warfarin Following Left Atrial Appendage Occlusion: A Study-Level Meta-Analysis

Fundamentals of Pharmacology: What You Need to Know as an Interventionalist

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Comparison of Effectiveness, Safety, and The Net Clinical Outcome Between Different Direct Oral Anticoagulants

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

What Is (and Is Not) Known About DAPT Decisions in Patients on Chronic Oral Anticoagulants

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

New Oral Anticoagulants: Are the Best Options

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content